Galecto Biotech
Updated: March 21, 2026
Hans Schambye - Co-Founder & CEO
Country: Denmark | Funding: $720.3M (+)
Founded: 2011
Website: https://galecto.com
Galecto develops galectin modulators for the treatment of severe diseases, including fibrosis and cancer. The company builds on more than 10 years of research into galectins and galectin modulators, which combined with a strong patent estate gives Galecto Biotech a unique platform.
Founded: 2011
Website: https://galecto.com
Galecto develops galectin modulators for the treatment of severe diseases, including fibrosis and cancer. The company builds on more than 10 years of research into galectins and galectin modulators, which combined with a strong patent estate gives Galecto Biotech a unique platform.
